Viewing Study NCT00486460


Ignite Creation Date: 2025-12-25 @ 2:15 AM
Ignite Modification Date: 2026-03-04 @ 9:07 AM
Study NCT ID: NCT00486460
Status: UNKNOWN
Last Update Posted: 2007-06-14
First Post: 2007-06-13
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase III Trial of Gemcitabine, Curcumin and Celebrex in Patients With Advance or Inoperable Pancreatic Cancer
Sponsor: Tel-Aviv Sourasky Medical Center
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Description Module Conditions Module Design Module Arms Interventions Module Eligibility Module Contacts Locations Module